In sintesi
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes is an EU-level competitive grant from European Commission for the horizon europe sector. Eligible applicants: Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions. The application deadline is September 21, 2027. Apply via the official listing at ec.europa.eu.
- Importo
- Vedi il bando
- Scadenza
- Sep 21, 2027
- Tipo
- Competitivo
- Stato
- In arrivo
Il programma
Vedere l'elenco ufficiale per i dettagli del programma completo.
Tradotto automaticamente - passa a English per il testo originale.
Chi può fare domanda
Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions.
Come fare domanda
Apply through the EU Funding & Tenders portal; submission is electronic via the portal's Submission Service before the topic deadline.
Fai domanda sulla fonte ufficiale